Literature DB >> 6924609

Circulating immune complexes in Indian childhood cirrhosis.

V Kalra, G D Harkiss, P J Lachmann, O P Ghai.   

Abstract

Considerable immunological dysfunction has been reported in Indian childhood cirrhosis (Chandra, 1970; Chawla et al., 1973). These observations suggest that the progressive tissue damage observed in this disease may have an immunological basis. To further test this hypothesis, sera from 18 patients with Indian childhood cirrhosis (ICC) and nine age-matched siblings were examined for the presence of soluble immune complexes and activation of complement. The presence of circulating immune complexes (CIC) in ICC is reported for the first time. Immune complexes were measured by the liquid phase 125I-Clq binding (Clq BA) and 125I-conglutinin binding (KBA) assays, and observed in 13/18 (72%) and 10/18 (56%) patients respectively. A significant correlation was found between the two tests. In contrast, only two out of nine siblings had elevated levels of immune complexes, and these were positive in both tests. Evidence was also obtained for in vivo activation of complement via the classical pathway. Total haemolytic complement (CH50) values were depressed in 13/18 (72%) patients, while C4 and C3 values were low in 5/16 (31%) and 4/18 (22%) patients respectively. C3 degradation products were found in substantial amounts in six patients. Complement levels in siblings were uniformly normal. These observations suggest that the immune complexes demonstrated may be of phlogistic significance and merit further characterization.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6924609      PMCID: PMC1536842     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Indian childhood cirrhosis.

Authors:  R K Chandra
Journal:  Med Chir Dig       Date:  1974

2.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

3.  Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver.

Authors:  M Bjorneboe; H Prytz; F Orskov
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

4.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

5.  Immunological picture in Indian childhood cirrhosis.

Authors:  R K Chandra
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

6.  An epidemiologic approach to Indian childhood cirrhosis.

Authors:  V Chawla; R K Chandra; I C Verma; O P Ghai
Journal:  Indian Pediatr       Date:  1973-02       Impact factor: 1.411

7.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

8.  Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.

Authors:  P Teisberg; E Gjone
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

9.  Alcoholic hyalin antigen (AHAg) and antibody (AHAb) in alcoholic hepatitis.

Authors:  N Kanagasundaram; S Kakumu; T Chen; C M Leevy
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

10.  Is primary biliary cirrhosis an immune complex disease?

Authors:  H C Thomas; B J Potter; S Sherlock
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

View more
  1 in total

1.  D-penicillamine in the treatment of Indian childhood cirrhosis--a preliminary report.

Authors:  B S Tomar; S Saxena; P Prakash; S Tomar; C Verma
Journal:  Indian J Pediatr       Date:  1983 Nov-Dec       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.